Viking Therapeutics Ownership | Who Owns Viking Therapeutics?


OverviewForecastFinancialsChartTranscripts

Viking Therapeutics Ownership Summary


Viking Therapeutics is owned by 68.37% institutional investors, 3.27% insiders, and 28.36% retail investors. Fmr is the largest institutional shareholder, holding 15.07% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.

VKTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockViking Therapeutics68.37%3.27%28.36%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.72M15.07%$672.63M
Vanguard group10.17M9.17%$409.34M
Blackrock6.03M5.82%$319.45M
Blackrock funding, inc. /de5.87M5.30%$236.33M
State street5.12M4.95%$271.54M
Jpmorgan chase2.16M1.95%$86.82M
Geode capital management1.88M1.70%$75.70M
Braidwell lp1.48M1.33%$59.54M
Ameriprise financial1.48M1.33%$59.54M
Massachusetts financial services co /ma/1.36M1.22%$54.62M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nationale-nederlanden powszechne towarzystwo emerytalne520.08K4.48%$27.57M
Boone capital management209.85K2.85%$8.44M
Apis capital advisors96.00K2.57%$3.86M
Profit investment management73.71K2.38%$2.97M
5am venture management189.59K1.82%$7.63M
Braidwell lp1.48M1.77%$59.54M
Altium capital management lp146.00K1.67%$5.88M
Toms capital investment management lp763.60K1.52%$40.48M
Artia global partners lp90.28K1.30%$3.63M
Lewis asset management41.27K1.27%$1.66M

Top Buyers

HolderShares% AssetsChange
State street5.12M0.01%1.80M
Norges bank1.28M0.01%1.28M
Massachusetts financial services co /ma/1.36M0.02%1.11M
Ameriprise financial1.48M0.02%1.03M
Balyasny asset management860.45K0.05%860.45K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---3.59M
Blackrock6.03M0.01%-2.25M
Perpetual---1.27M
International assets investment management18.28K0.06%-985.76K
Westfield capital management co lp---930.37K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.28M0.01%1.28M$51.46M
Toms capital investment management lp763.60K1.52%763.60K$40.48M
Raymond james financial618.47K0.01%618.47K$24.89M
Parallax volatility advisers268.88K0.02%268.88K$10.82M
Aquatic capital management209.13K0.23%209.13K$8.42M

Sold Out

HolderChange
Sachetta-1.00
Capital advisors-8.00
Park place capital-9.00
Main street group-10.00
Scarborough advisors-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024414-10.78%75,828,361-8.31%681.23%216-21.17%1146.54%
Sep 30, 20244606.48%82,562,3852.80%741.41%2728.80%106-4.50%
Jun 30, 20244280.71%80,251,5740.48%771.08%247-12.72%11124.72%
Mar 31, 202442593.18%79,870,2574.63%841.29%283154.96%8971.15%
Dec 31, 20232208.91%76,339,364-1.05%801.33%11114.43%521.96%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O5.10M4.61%70.32K
Fidelity Growth Compy Commingled Pl S3.36M2.99%-2.00M
Vanguard Total Stock Mkt Idx Inv3.34M2.97%12.90K
Vanguard US Total Market Shares ETF3.32M2.96%2.50K
Vanguard Small Cap Index2.70M2.41%2.21K
Fidelity Growth Company Fund2.29M2.04%-1.48M
SPDR® S&P Biotech ETF2.25M2.01%-24.11K
Vanguard Institutional Extnd Mkt Idx Tr1.69M1.51%2.36K
Vanguard Small Cap Growth Index Inv1.52M1.35%-8.95K
JPMorgan Mid Cap Growth I1.15M1.02%394.72K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 31, 2025Rouan Sarah Kathryn-Buy$29.94K
Jan 06, 2025Lian Brian President & CEOSell$7.49M
Jan 06, 2025Lian Brian President & CEOSell$823.02K
Jan 06, 2025Mancini Marianna Chief Operating OfficerSell$2.10M
Jan 06, 2025Mancini Marianna Chief Operating OfficerSell$220.91K

Insider Transactions Trends


DateBuySell
2025 Q1-6
2024 Q4-11
2024 Q3-25
2024 Q2-9
2024 Q1-12

VKTX Ownership FAQ


Who Owns Viking Therapeutics?

Viking Therapeutics shareholders are primarily institutional investors at 68.37%, followed by 3.27% insiders and 28.36% retail investors. The average institutional ownership in Viking Therapeutics's industry, Biotech Stocks , is 68.48%, which Viking Therapeutics falls below.

Who owns the most shares of Viking Therapeutics?

Viking Therapeutics’s largest shareholders are Fmr (16.72M shares, 15.07%), Vanguard group (10.17M shares, 9.17%), and Blackrock (6.03M shares, 5.82%). Together, they hold 30.07% of Viking Therapeutics’s total shares outstanding.

Does Blackrock own Viking Therapeutics?

Yes, BlackRock owns 5.82% of Viking Therapeutics, totaling 6.03M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 319.45M$. In the last quarter, BlackRock decreased its holdings by -2.248M shares, a -27.17% change.

Who is Viking Therapeutics’s biggest shareholder by percentage of total assets invested?

Nationale-nederlanden powszechne towarzystwo emerytalne is Viking Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.48% of its assets in 520.08K Viking Therapeutics shares, valued at 27.57M$.

Who is the top mutual fund holder of Viking Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Viking Therapeutics shares, with 4.61% of its total shares outstanding invested in 5.1M Viking Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools